| Nome do produto |
Methotrexate sodium |
| Sinônimos |
L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, sodium salt; MTX sodium; Methotrexate sodium salt; Sodium L-(+)-methotrexate; Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, sodium salt; sodium 2,4-diamino-6-{[{4-[(1-carboxy-3-carboxylatopropyl)carbamoyl]phenyl}(methyl)amino]methyl}pteridine; sodium 2,4-diamino-6-{[(4-{[(1S)-1-carboxy-3-carboxylatopropyl]carbamoyl}phenyl)(methyl)amino]methyl}pteridine; L-glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, monosodium salt; disodium (2S)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)amino]pentanedioate |
| Fórmula molecular |
C20H20N8Na2O5 |
| Peso Molecular |
498.4029 |
| InChI |
InChI=1/C20H22N8O5.2Na/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);;/q;2*+1/p-2/t13-;;/m0../s1 |
| CAS Registry Number |
15475-56-6 |
| EINECS |
239-495-5 |
| Estrutura Molecular |
|
| Símbolos de perigo |
|
| Códigos de risco |
|
| Descrição da Segurança |
|
|
